| Last Action | 01/04/22: to Committee on Committees (H) |
|---|---|
| Title | AN ACT relating to coverage for diabetes treatment. |
| Bill Documents | Introduced |
| Fiscal Impact Statement | Health Mandate |
| Bill Request Number | 945 |
| Sponsors | D. Bentley, P. Minter, S. Baker, K. Banta, J. Blanton, T. Bojanowski, K. Bratcher, R. Bridges, G. Brown Jr., T. Burch, J. Calloway, M. Cantrell, J. Decker, J. Donohue, D. Elliott, J. Fischer, D. Fister, P. Flannery, K. Flood, C. Freeland, C. Fugate, D. Graham, D. Hale, M. Hart, A. Hatton, R. Heath, S. Heavrin, R. Huff, M. Imes, J. Jenkins, DJ Johnson, K. King, N. Kirk-McCormick, N. Kulkarni, S. Lewis, M. Marzian, C. Massey, B. McCool, S. McPherson, M. Meredith, C. Miller, J. Miller, R. Palumbo, M. Prunty, J. Raymond, B. Reed, S. Riley, R. Roberts, S. Santoro, S. Sharp, S. Sheldon, P. Stevenson, A. Tackett Laferty, W. Thomas, K. Timoney, J. Tipton, T. Truett, K. Upchurch, R. Webber, B. Wesley, S. Westrom, B. Wheatley, L. Willner |
| Summary of Original Version | Amend KRS 304.17A-148 to require that cost sharing for noninsulin drugs and certain equipment and supplies necessary for the treatment of diabetes not exceed certain cost-sharing thresholds; prohibit insurers from conducting or imposing utilization review for diabetes treatment prescribed by a health care provider; EFFECTIVE January 1, 2023. |
| Index Headings of Original Version |
Health Benefit Mandate - Diabetes treatment, insurance requirements, health plan Diseases - Diabetes treatment, insurance requirements Drugs and Medicines - Diabetes drugs, equipment, and supplies, cost-sharing limitation Effective Dates, Delayed - Diabetes treatment, insurance requirements, January 1, 2023 Insurance, Health - Diabetes treatment, cost-sharing limitation Insurance, Health - Diabetes treatment, utilization review prohibition State Employees - Diabetes treatment, insurance requirements, health plan |
| 11/23/21 |
|
|---|---|
| 01/04/22 |
|
Last updated: 2/8/2023 2:57 PM (EST)